Goldman Sachs’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-104,244
Closed -$636K 5851
2021
Q3
$636K Sell
104,244
-1,009,901
-91% -$6.16M ﹤0.01% 4256
2021
Q2
$9.17M Buy
1,114,145
+95,794
+9% +$788K ﹤0.01% 2312
2021
Q1
$9.12M Buy
1,018,351
+190,824
+23% +$1.71M ﹤0.01% 2272
2020
Q4
$9.55M Sell
827,527
-82,769
-9% -$955K ﹤0.01% 2087
2020
Q3
$9.48M Buy
910,296
+184,270
+25% +$1.92M ﹤0.01% 1981
2020
Q2
$9.55M Buy
726,026
+621,879
+597% +$8.18M ﹤0.01% 1972
2020
Q1
$820K Sell
104,147
-58,545
-36% -$461K ﹤0.01% 3219
2019
Q4
$3.37M Buy
162,692
+33,045
+25% +$684K ﹤0.01% 2650
2019
Q3
$1.78M Sell
129,647
-21,759
-14% -$298K ﹤0.01% 2900
2019
Q2
$1.86M Buy
151,406
+26,549
+21% +$327K ﹤0.01% 2855
2019
Q1
$1.56M Sell
124,857
-279,191
-69% -$3.48M ﹤0.01% 3056
2018
Q4
$4.57M Buy
404,048
+244,709
+154% +$2.77M ﹤0.01% 2390
2018
Q3
$2.98M Buy
159,339
+40,802
+34% +$763K ﹤0.01% 2677
2018
Q2
$3.06M Buy
118,537
+15,961
+16% +$413K ﹤0.01% 2665
2018
Q1
$2.3M Buy
102,576
+36,661
+56% +$822K ﹤0.01% 2795
2017
Q4
$1.65M Buy
65,915
+9,159
+16% +$229K ﹤0.01% 2917
2017
Q3
$1.37M Buy
56,756
+4,953
+10% +$120K ﹤0.01% 3072
2017
Q2
$1.05M Sell
51,803
-13,333
-20% -$269K ﹤0.01% 3128
2017
Q1
$1.75M Buy
65,136
+31,817
+95% +$856K ﹤0.01% 2817
2016
Q4
$634K Buy
33,319
+341
+1% +$6.49K ﹤0.01% 3322
2016
Q3
$644K Buy
32,978
+12,119
+58% +$237K ﹤0.01% 3288
2016
Q2
$312K Sell
20,859
-13,524
-39% -$202K ﹤0.01% 3604
2016
Q1
$316K Buy
34,383
+7,272
+27% +$66.8K ﹤0.01% 3515
2015
Q4
$522K Buy
27,111
+7,671
+39% +$148K ﹤0.01% 3229
2015
Q3
$289K Sell
19,440
-51
-0.3% -$758 ﹤0.01% 3626
2015
Q2
$427K Sell
19,491
-1,019
-5% -$22.3K ﹤0.01% 3448
2015
Q1
$462K Buy
+20,510
New +$462K ﹤0.01% 3364